The FnBPA from methicillin-resistant Staphylococcus aureus promoted development of oral squamous cell carcinoma

References

• Dhanuthai K, Rojanawatsirivej S, Thosaporn W, et al. Oral cancer: a multicenter study. Med Oral Patol Oral Cir Buccal. 2018;23(1): E23–E29.
   PubMed Web of Science ®Google Scholar
• Lu YC, Chen YJ, Wang HM, et al. Oncogenic Function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling. Cancer Prev Res (Phila). 2012;5(4):665–10.
   PubMed Web of Science ®Google Scholar
• Wen L, Mu W, Lu H, et al. Porphyromonas gingivalis promotes oral squamous cell carcinoma progression in an immune microenvironment. J Dent Res. 2020;99(6):666–675.
   PubMed Web of Science ®Google Scholar
• Sasahira T, Kurihara M, Bhawal UK. Sasahira T, Kurihara M, Bhawal UK, et al. Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer. Br J Cancer. 2012;107(4):700–706.
   PubMed Web of Science ®Google Scholar
• Irani S. Distant metastasis from oral cancer: a review and molecular biologic aspects. J Int Soc Prev Community Dent. 2016;6(4):265–271.
   Google Scholar
• Legge CJ, Colley HE, Lawson MA, et al. Targeted magnetic nanoparticle hyperthermia for the treatment of oral cancer. J Oral Pathol Med. 2019;48(9):803–809.
   Web of Science ®Google Scholar
• Stashenko P, Yost S, Choi Y, et al. The oral mouse microbiome promotes tumorigenesis in oral squamous cell carcinoma. mSystems. 2019;4(4):e00323–19.
   PubMed Web of Science ®Google Scholar
• McCormack MG, Smith AJ, Akram AN, et al. Staphylococcus aureus and the oral cavity: an overlooked source of carriage and infection? Am J Infect Control. 2015;43(1):35–37.
   PubMed Web of Science ®Google Scholar
• Panghal M, Kaushal V, Kadayan S, et al. Incidence and risk factors for infection in oral cancer patients undergoing different treatments protocols. BMC Oral Health. 2012;12:22.
   Web of Science ®Google Scholar
• Hattar K, Reinert CP, Sibelius U, et al. Lipoteichoic acids from Staphylococcus aureus stimulate proliferation of human non-small-cell lung cancer cells in vitro. Cancer Immunol Immunother. 2017;66(6):799–809.
   Web of Science ®Google Scholar
• Liu T, Li L, Yin L, et al. Superantigen staphylococcal enterotoxin C1 inhibits the growth of bladder cancer. Biosci Biotechnol Biochem. 2017;81(9):1741–1746.
   PubMed Web of Science ®Google Scholar
• Wang YX, Liu SY, Li BL, et al. Staphylococcus aureus induces COX-2-dependent proliferation and malignant transformation in oral keratinocytes. J Oral Microbiol. 2019;11(1):1643205.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ren B, Zhou X, et al. Growth and adherence of Staphylococcus aureus were enhanced through the PGE2 produced by the activated COX-2/PGE2 pathway of infected oral epithelial cells. PloS one. 2017;12(5):e0177166.
   PubMed Web of Science ®Google Scholar
• Methicillin-Resistant BM. Staphylococci. J Clin Pathol. 1961;14(4):385.
   Web of Science ®Google Scholar
• Lakhundi S, Zhang K. Methicillin-Resistant Staphylococcus aureus: molecular characterization, evolution, and epidemiology. Clin Microbiol Rev. 2018;31(4):e00020–18.
   PubMed Web of Science ®Google Scholar
• Hanberger H, Walther S, Leone M, et al. Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study. Int J Antimicrob Agents. 2011;38(4):331–335.
   PubMed Web of Science ®Google Scholar
• Miyake M, Ohbayashi Y, Iwasaki A, et al. Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) and use of a nasal mupirocin ointment in oral cancer inpatients. J Oral Maxillofac Surg. 2007;65(11):2159–2163.
   Web of Science ®Google Scholar
• Yamashita K, Ohara M, Kojima T, et al. Prevalence of drug-resistant opportunistic microorganisms in oral cavity after treatment for oral cancer. J Oral Sci. 2013;55(2):145–155.
   Web of Science ®Google Scholar
• Avery CM, Gandhi N, Peel D, et al. Indications and outcomes for 100 patients managed with a pectoralis major flap within a UK maxillofacial unit. Int J Oral Maxillofac Surg. 2014;43(5):546–554.
   Web of Science ®Google Scholar
• Foster TJ. The remarkably multifunctional fibronectin binding proteins of Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 2016;35(12):1923–1931.
   PubMed Web of Science ®Google Scholar
• Tan X, Coureuil M, Charbit A, et al. Multitasking actors of Staphylococcus aureus metabolism and virulence. Trends Microbiol. 2020;28(1):6–9.
   Web of Science ®Google Scholar
• Yang X, Qian S, Yao K, et al. Multiresistant ST59-SCC mec IV-t437 clone with strong biofilm-forming capacity was identified predominantly in MRSA isolated from Chinese children. BMC Infect Dis. 2017;17(1):733.
   Google Scholar
• Sofat N, Robertson SD, Wait R. Fibronectin III 13-14 domains induce joint damage via toll-like receptor 4 activation and synergize with interleukin-1 and tumour necrosis factor. J Innate Immun. 2012;4(1):69–79.
   Web of Science ®Google Scholar
• Bhattacharyya S, Tamaki Z, Wang WX, et al. Fibronectin(EDA) promotes chronic cutaneous fibrosis through toll-like receptor signaling. Sci Transl Med. 2014;6(232):232ra50.
   Web of Science ®Google Scholar
• Gondokaryono SP, Ushio H, Niyonsaba F, et al. The extra domain A of fibronectin stimulates murine mast cells via Toll-like receptor 4. J Leukoc Biol. 2007;82(3):657–665.
   Web of Science ®Google Scholar
• Bai LX, Mao R, Wang JT, et al. ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins. Med Oncol. 2015;32(3):57.
   Web of Science ®Google Scholar
• Wang G, Xu B, Shi F, et al. Protective effect of methane-rich saline on acetic acid-induced ulcerative colitis via blocking the TLR4/NF-kappaB/MAPK pathway and promoting IL-10/JAK1/STAT3-mediated anti-inflammatory response. Oxid Med Cell Longev. 2019;2019:7850324.
   PubMed Web of Science ®Google Scholar
• Jiang XH, Lv B, Wang Y, et al. Bactericidal mechanisms and effector targets of TiO2 and Ag-TiO2 against Staphylococcus aureus. J Med Microbiol. 2017;66(4):440–446.
   Web of Science ®Google Scholar
• Guo H, Ren B, Dai H, et al. Reversal of methicillin resistance in Staphylococcus aureus by the anthelmintic avermectin. Int J Antimicrob Agents. 2014;44(3):274–276.
   Web of Science ®Google Scholar
• Wu J, Li L, Wang Y, et al. The HSP 90/Akt pathway may mediate artemether‐induced apoptosis of Cal27 cells. FEBS Open Bio. 2019;9(10):1726–1733.
   Web of Science ®Google Scholar
• Zhuo ZJ, Xiao MJ, Lin HR, et al. Novel betulin derivative induces anti-proliferative activity by G2/M phase cell cycle arrest and apoptosis in Huh7 cells. Oncol Lett. 2018;15(2):2097–2104.
   Web of Science ®Google Scholar
• Wang Z, Zhou Y, Han Q, et al. Synonymous point mutation of gtfB gene caused by therapeutic X-rays exposure reduced the biofilm formation and cariogenic abilities of Streptococcus mutans. Cell Biosci. 2021;11(1):91.
   Web of Science ®Google Scholar
• Zhou Y, Yang H, Zhou X, et al. Lovastatin synergizes with itraconazole against planktonic cells and biofilms of Candida albicans through the regulation on ergosterol biosynthesis pathway. Appl Microbiol Biotechnol. 2018;102(12):5255–5264.
   PubMed Web of Science ®Google Scholar
• Percie du Sert N, Hurst V, Ahluwalia A, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410.
   PubMed Web of Science ®Google Scholar
• Lin NN, Wang P, Zhao D, et al. Significance of oral cancer‐associated fibroblasts in angiogenesis, lymphangiogenesis, and tumor invasion in oral squamous cell carcinoma. J Oral Pathol Med. 2017;46(1):21–30.
   Web of Science ®Google Scholar
• Cataldi A, Nascimento AL, Acosta A, et al. Research on bacterial virulence in the developing countries. Biomed Res Int. 2015;2015:972187.
   Web of Science ®Google Scholar
• Otto T, Sicinski P. Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer. 2017;17(2):93–115.
   PubMed Web of Science ®Google Scholar
• Anders L, Ke N, Hydbring P, et al. A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells. Cancer Cell. 2011;20(5):620–634.
   PubMed Web of Science ®Google Scholar
• Bartek J, Falck J, Lukas J. CHK2 kinase–a busy messenger. Nat Rev Mol Cell Biol. 2001;2(12):877–886.
   PubMed Web of Science ®Google Scholar
• Osborn AJ, Elledge SJ, Zou L. Checking on the fork: the DNA-replication stress-response pathway. Trends Cell Biol. 2002;12(11):509–516.
   Web of Science ®Google Scholar
• Gries CM, Biddle T, Bose JL, et al. Staphylococcus aureus fibronectin binding protein a mediates biofilm development and infection. Infect Immun. 2020;88(5):e00859–19.
   Web of Science ®Google Scholar
• Speziale P, Pietrocola G. The multivalent role of fibronectin-binding proteins A and B (FnBPA and FnBPB) of Staphylococcus aureus in host infections. Front Microbiol. 2020;11:2054.
   PubMed Web of Science ®Google Scholar
• Peacock SJ, Day NPJ, Thomas MG. Peacock SJ, Day NP, Thomas MG, et al. Clinical isolates of Staphylococcus aureus exhibit diversity in fnb genes and adhesion to human fibronectin. J Infect. 2000;41(1):23–31.
   PubMed Web of Science ®Google Scholar
• Chen HY, Lin MH, Chen CC, et al. The expression of fibronectin is significantly suppressed in macrophages to exert a protective effect against Staphylococcus aureus infection. BMC Microbiol. 2017 17; 17(1): 92.
   Google Scholar
• Hayashi Y, Shino Y, Saito K, et al. c-Jun-mediated repression and transactivation of fibronectin. Mol Med Rep. 2008;1(1):99–103.
   Web of Science ®Google Scholar
• Muhammad N, Bhattacharya S, Steele R, et al. Involvement of c-Fos in the promotion of cancer stem-like cell properties in head and neck squamous cell carcinoma. Clin Cancer Res. 2017;23(12):3120–3128.
   Web of Science ®Google Scholar
• Han XR, Zha Z, Yuan HX, et al. KDM2B/FBXL10 targets c-Fos for ubiquitylation and degradation in response to mitogenic stimulation. Oncogene. 2016;35(32):4179–4190.
   PubMed Web of Science ®Google Scholar
• Nemoto T, Kubota S, Ishida H, et al. Ornithine decarboxylase, mitogen-activated protein kinase and matrix metalloproteinase-2 expressions in human colon tumors. World J Gastroenterol. 2005;11(20):3065–3069.
   Web of Science ®Google Scholar
• Shin I, Kim S, Song H, et al. H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. J Biol Chem. 2005;280(15):14675–14683.
   Web of Science ®Google Scholar
• Song H, Ki SH, Kim SG, et al. Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells. Cancer Res. 2006;66(21):10487–10496.
   Web of Science ®Google Scholar
• Zong Y, Zhou Y, Liao B, et al. The interaction between the microbiome and tumors. Front Cell Infect Microbiol. 2021;11:673724.
   Web of Science ®Google Scholar
• Mima K, Sukawa Y, Nishihara R, et al. Fusobacterium nucleatum and T cells in colorectal carcinoma. JAMA Oncol. 2015;1(5):653–661.
   PubMed Web of Science ®Google Scholar
• Burns MB, Blekhman R. Integrating tumor genomics into studies of the microbiome in colorectal cancer. Gut Microbes. 2019;10(4):547–552.
   PubMed Web of Science ®Google Scholar
• Burns MB, Montassier E, Abrahante J, et al. Colorectal cancer mutational profiles correlate with defined microbial communities in the tumor microenvironment. PLoS Genet. 2018;14(6):e1007376.
   PubMed Web of Science ®Google Scholar
• Manzoor SS, Doedens A, Burns MB. The promise and challenge of cancer microbiome research. Genome Biol. 2020;21(1):131.
   PubMed Web of Science ®Google Scholar
• Avner BS, Fialho AM, Chakrabarty AM. Overcoming drug resistance in multi-drug resistant cancers and microorganisms: a conceptual framework. Bioengineered. 2012;3(5):262–270.
   PubMed Web of Science ®Google Scholar
• Dharmaraja AT. Role of reactive oxygen species (ROS) in therapeutics and drug resistance in cancer and bacteria. J Med Chem. 2017;60(8):3221–3240.
   PubMed Web of Science ®Google Scholar
• Yoo MH, Xu XM, Carlson BA, et al. Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells. J Biol Chem. 2006;281(19):13005–13008.
   Web of Science ®Google Scholar